NLM logo
14 results
  1. ... PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS. Tree locations: Camptothecin D03.132.151.425 New MeSH Headings for 2019 Listed in alphabetical order ...
  2. ... lOInlverslte Laval / edited by Marcel Martin, Louis Dlonne. - New York : Stratton Intercontinental Medical Book Corp., c!976. Ix, 182 p. : 111.-- (Symposia specialists medical books) 1. Immunotherapy - congresses 2. Neoplasms - therapy - congresses 3. Neoplasms - Immunology - congresses I. Dlonne, Louis, ...
  3. ... substances. The ability to determine Pharmacologic and/or Therapeutic Categories for many drugs should be a useful addition for searchers interested in pharmaceutical substances; the additional Locator values not only give new pointers to files carrying pertinent data, but may ...
  4. ... A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON- SMALL CELL LUNG CANCER. Parent Heading: Taxoids D02.455.426.392.368.242.888.389 D02.455.849.291.850.389 New MeSH Headings for 2019 Listed in alphabetical order with Heading, Scope ...
  5. ... NATO International Advanced Study Institute on Antiviral Mechanisms for the Control of Neoplasia, ... use - * ses 2 Antiviral Agents - therapeutic use - congresses ...
  6. ... Synopsis from Source: “The Parker Institute for Cancer Immunotherapy, started by Napster founder Sean Parker, and the Cancer Research ...  Synopsis from Source: “ ...
  7. ... INHIBITORS. FX: Platelet Aggregation Inhibitors Tree locations: Drug Therapy, ... New MeSH Headings for 2020 Listed in alphabetical order with Heading, Scope ...
  8. ... NEW VALUES 1. Form of Name (FN) An additional value "7" has been added ... 2. Series Treatment Code (SM) New values have been added to ...
  9. ... cancer testing set (110 patients, 1,827 drug events). This method for cancer treatment plan recognition may provide clinicians and systems an ... expression (GE) each before, after, and across trastuzumab treatment for the ... tumors. Differential GE between responsive and resistant tumors at ...
  10. ... GOVERNMENT/non-gcvernment funding of cancer detection and therapy GYNECOLOGIC neoplasms DiethylstiIbestrol and HANDICAPPED Dental care for the HANDICAPPED patients Rights of mentally HEALTH aspects ...
previous · 1 · 2 · next